Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for medical industry professionals · Thursday, April 19, 2018 · 443,001,214 Articles · 3+ Million Readers

Female Sexual Dysfunction - Change in LIfestyle Have Given Rise to Sexual Dysfunction in Past Few Years,

Female Sexual Dysfunction

PUNE, MAHARASHTRA, INDIA, March 6, 2018 / -- Female Sexual Dysfunction


Clinical trial report, “Female Sexual Dysfunction Global Clinical Trials Review, H2, 2017" provides an overview of Female Sexual Dysfunction clinical trials scenario. This report provides top line data relating to the clinical trials on Female Sexual Dysfunction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.

Report also provides prominent drugs for in-progress trials (based on number of ongoing trials).  The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Click here for sample report @

Major Players:

Sprout Pharmaceuticals Inc

Emotional Brain BV

Allergan Plc

Pfizer Inc

H. Boehringer Sohn AG & Co KG

ANI Pharmaceuticals Inc

Female Sexual Dysfunction - Competitive Analysis

Key players are making innovative developments in Female Sexual Dysfunction industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector


The report provides a snapshot of the global clinical trials landscape.

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status.

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report reviews key players involved Systemic Female Sexual Dysfunction therapeutics and enlists all their major and minor projects

The report assesses Systemic Female Sexual Dysfunction therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type


For Detailed Reading Please visit @


About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:


Partner Relations & Marketing Manager

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here

Powered by EIN Presswire